Trial · NCT03155997
Adverse events848
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
61 to 80 of 848
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Influenza like illness | General disorders | 150 mg Abemaciclib + Endocrine Therapy | 141 | 2,791 | 180 |
| other | Influenza like illness | General disorders | Endocrine Therapy | 112 | 2,800 | 152 |
| other | Malaise | General disorders | 150 mg Abemaciclib + Endocrine Therapy | 88 | 2,791 | 109 |
| other | Malaise | General disorders | Endocrine Therapy | 29 | 2,800 | 29 |
| other | Mucosal inflammation | General disorders | 150 mg Abemaciclib + Endocrine Therapy | 72 | 2,791 | 90 |
| other | Mucosal inflammation | General disorders | Endocrine Therapy | 21 | 2,800 | 32 |
| other | Oedema peripheral | General disorders | 150 mg Abemaciclib + Endocrine Therapy | 169 | 2,791 | 200 |
| other | Oedema peripheral | General disorders | Endocrine Therapy | 103 | 2,800 | 119 |
| other | Pain | General disorders | 150 mg Abemaciclib + Endocrine Therapy | 60 | 2,791 | 64 |
| other | Pain | General disorders | Endocrine Therapy | 53 | 2,800 | 58 |
| other | Peripheral swelling | General disorders | 150 mg Abemaciclib + Endocrine Therapy | 51 | 2,791 | 58 |
| other | Peripheral swelling | General disorders | Endocrine Therapy | 53 | 2,800 | 61 |
| other | Pyrexia | General disorders | 150 mg Abemaciclib + Endocrine Therapy | 227 | 2,791 | 299 |
| other | Pyrexia | General disorders | Endocrine Therapy | 114 | 2,800 | 130 |
| other | Hepatic steatosis | Hepatobiliary disorders | 150 mg Abemaciclib + Endocrine Therapy | 41 | 2,791 | 42 |
| other | Hepatic steatosis | Hepatobiliary disorders | Endocrine Therapy | 35 | 2,800 | 35 |
| other | Bronchitis | Infections and infestations | 150 mg Abemaciclib + Endocrine Therapy | 42 | 2,791 | 50 |
| other | Bronchitis | Infections and infestations | Endocrine Therapy | 40 | 2,800 | 44 |
| other | Cellulitis | Infections and infestations | 150 mg Abemaciclib + Endocrine Therapy | 37 | 2,791 | 43 |
| other | Cellulitis | Infections and infestations | Endocrine Therapy | 28 | 2,800 | 31 |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03155997/events?page=4